Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer

This publication has 15 references indexed in Scilit:

• Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis
  British Journal of Cancer, 1991
• Decreased fucose incorporation in cell surface carbohydrates is associated with inhibition of invasion
  Clinical & Experimental Metastasis, 1989
• Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
  Advances in Cancer Research, 1989
• Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum
  Cancer, 1988
• Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis marker
  Journal of Cellular Biochemistry, 1988
• Elevated levels of abnormally-fucosylated haptoglobins in cancer sera
  British Journal of Cancer, 1987
• A simple, reproducible and cheap batch method for the analysis of serum glycoproteins using Sepharose-coupled lectins and silver staining
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1987
• Use of N-acetyl-2′-O-methyllactosamine as a specific acceptor for the determination of α-l-(1→3)-fucosyltransferase in human serum
  Analytical Biochemistry, 1986
• Evaluation of two plasma fucosyltransferases as marker enzymes in non-Hodgkin's lymphoma
  Cancer, 1978
• Glycosyltransferase Levels in Tumors Metastatic to Liver and in Uninvolved Liver Tissue 2
  JNCI Journal of the National Cancer Institute, 1977